Blue Dog Democrats

As corporate-backed Democrats threaten to block the party's reconciliation bill, their talking points draw on support from deficit scold allies among party leaders and well-funded ideological groups.

The largest drugmakers spent $56 billion more on stock buybacks and dividends than on research and development from 2016 to 2020, according to a new House committee report.

The Nashville Democrat, chair of the House subcommittee overseeing nuclear weapons programs, received max contributions last cycle from the PACs of several top defense contractors.